USPTO trademark

ATEV

Opposition periodUSPTOWord markClass 5Class 42Class 44

"ATEV" is a word mark owned by Humacyte Global, Inc., filed at the USPTO on August 2, 2024. It is in its opposition period and covers classes 5, 42 and 44.

Official USPTO record
ATEV trademark as filed
As filed with the USPTO
Status
Opposition period
Since December 6, 2025
Filed
August 2, 2024
Registered
Not yet
Expires
Not recorded
Application no.
98679748
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns ATEV

The owner and representative on file with the office.

Owner

Humacyte Global, Inc.

Durham, United States

Representative

Brendan J. Hughes

Cooley LLP

Goods and services

What the mark covers

The products and services ATEV is filed for, grouped by Nice class.

  • Bioengineered human connective tissue intended for subsequent implantation; biological implants comprising connective tissue; biological tissue grafts; vascular grafts; bioengineered blood vessels comprising connective tissue intended for subsequent implantation; biological connective tissue implants comprising tissue for use in surgery and regenerative medicine; human tissue substitute comprising connective tissue material derived from biological tissue intended for subsequent implantation.

  • Product development services, namely, developing biological tissue and bioengineered cells and tissue for medical and clinical use; Research and development of bioengineered tissue; Scientific research in the field of bioengineering and regenerative medicine; Providing information in the field of bioengineering

  • Providing information in the field of regenerative medicine

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Extension of time to oppose process - terminated
  2. Opposition instituted no. 999999
  3. Extension of time to oppose received
  4. Official gazette publication confirmation e-mailed
  5. Published for opposition
  6. Notification of notice of publication e-mailed
  7. Approved for pub - principal register
  8. Teas/email correspondence entered
  9. Correspondence received in law office
  10. Teas response to office action received

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About ATEV

Who owns the trademark "ATEV"?

The USPTO trademark "ATEV" (application 98679748) is owned by Humacyte Global, Inc.

What is the status of "ATEV"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ATEV and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2949-7e1d-759d-b1d3-7e0edf884b04
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2949-7e1d-759d-b1d3-7e0edf884b04",
  "object": "trademark",
  "mark_text": "ATEV",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "98679748",
  "filing_date": "2024-08-02",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "Humacyte Global, Inc.",
      "entity_id": null
    }
  ]
}